World Class Innovation, World Class Path to Market

There is no one obvious path to commercial return for a new compound or a new technology. As early in development as possible, awareness of, and planning for, commercial value is critical to optimizing investment and eventual return. How do you determine the path that will add the most value, while balancing risk and reward in early stage? How do you know when (or if) to look for a strategic partnership? The discipline of path-to-market strategy is about maximizing return on invention, embracing possibility and probability, uncertainty and the power of an early story.

Topics will include: 

• Development of strategic choices (FIVE-X)
• Sequencing of lifecycle and gateway launches
• Optimizing value in launching your own asset
• Positioning earlier than the other guys
• Disruption in healthcare, and the new possibilities

Speakers:
Mike Rea | Chief Executive Officer, IDEA Pharm read bio »
Geoff Birkett, Principal, US Business, “New IDEA” read bio »

Agenda:
9:30AM | Registration Opens, Networking
10:00AM | Introduction, Innovation: Return on Invention
10:30AM | Path to Market: Planning Path To Market when you’re going all the way yourself
11:00AM | Path to Market: Planning Path To Market when you’re going to look to partner
11:30AM | Q&A
12:00PM | Networking Reception
1:00PM | Program Close

Fees:
$15 | General Public
$10 | Student/Academic
$35 | At the door

Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

To register, click here.
LSO MEMBERS: Use Discount Code "LSO" for complimentary tickets.